The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: Own- and cross-price elasticities

Health Policy

Volumn 82, Issue 3, 2007, Pages 340-347

  Li, Xin ^a,b   Guh, Daphne ^b   Lacaille, Diane ^a,c   Esdaile, John ^a,c   Anis, Aslam H ^a,b,c  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ST PAUL S HOSPITAL   (Canada)

^c ARTHRITIS RESEARCH CENTRE OF CANADA   (Canada)

Author keywords

Cost; Economics; Elasticity; Rheumatoid arthritis; Substitution

Indexed keywords

CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG;

AGED; ARTICLE; DRUG COST; DRUG LEGISLATION; DRUG USE; FEMALE; GERIATRIC PATIENT; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRESCRIPTION; RHEUMATOID ARTHRITIS;

AGED; AGED, 80 AND OVER; ARTHRITIS, RHEUMATOID; BRITISH COLUMBIA; COHORT STUDIES; COST SHARING; FEMALE; HEALTH EXPENDITURES; HEALTH SERVICES; HUMANS; MALE; NATIONAL HEALTH PROGRAMS; PRESCRIPTIONS, DRUG;

EID: 34250753206     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2006.11.002     Document Type: Article

References (28)

1. Hux JE, Naylor CD, Fielding DA. The Ontario Drug Benefit Program copayment: its impact on access for Ontario seniors and charges to the program. Toronto: Institute for Clinical Evaluative Sciences in Ontario; April 24, 1997.
2. Johnson R.E., Goodman M.J., Hornbrook M.C., et al. The impact of increasing patient prescription drug cost sharing on therapeutic classes of drugs received and on the health status of elderly HMO members. Health Service Research 32 (1997) 103-122
3. Poirier S., LeLorier J., Page V., and Lacour A. The effect of a $2 co-payment on prescription refill rates of Quebec elderly and its relationship to socio-economic status. Canadian Pharmaceuticals Journal 131 1 (1998) 30-34
4. Stuart B., and Grana J. Are prescribed and over-the-counter medicines economic substitutes? A study of the effects of health insurance on medicine choices by the elderly. Medical Care 33 (1995) 487-501
5. Stuart B., and Zacker C. Who bears the burden of Mediaid drug copayment policies?. Health Affairs 18 (1999) 201-212
6. Tamblyn R., Laprise R., Hanley J.A., et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. JAMA 285 4 (2001) 421-429
7. Coulson N.E., Stuart B.C., and Insurance. Choice and the demand for prescription drugs. Southern Economics Journal 61 4 (1995) 1146-1157
8. Gardner L.B., Javitz H.S., and Recine B.P. Pharmaceutical use and cost among insured elderly (March 1997), Agency for Health Care Policy and Research
9. Johnson R.E., Goodman M.J., Hornbrook M.C., et al. The effect of increased prescription drug cost-sharing on medical care utilization and expenses of elderly health maintenance organization members. Medical Care 35 11 (1997) 1119-1131
10. Manning W.G., Newhouse J.P., Duan N., Keeler E.B., Leibowitz A., and Marquis M.S. Health insurance and the demand for medical care: evidence from a randomized experiment. American Economic Review 77 (1987) 251-277
11. Newhouse J.P. The Insurance Experiment Group. Free for all? Lessons from the Rand health insurance experiment (1993), Harvard University Press, Cambridge and London
12. Escarce J.J., Kapur K., Joyce G.F., et al. Medical care expenditures under gatekeeper and point-of-service arrangements. Health Service Research 36 6 (2001) 1037-1057
13. Joyce G.F., Kapur K., Van Vorst K.A., et al. Visits to primary care doctors and specialists under gatekeeper and point-of-service arragemnents. American Journal of Managed Care 6 11 (2000) 1189-1196
14. Kapur K., Joyce G.F., Van Vorst K.A., et al. Expenditures for doctor services under alternative models of managed care. Medical Care Research and Review 57 2 (2000) 161-181
15. Winkelmann R. Co-payments for prescription drugs and the demand for doctor visits-evidence from a natural experiment. Health Economics 13 11 (2004) 1081-1089
16. Auten G., and Carroll R. The effect of income taxes on household income. Review of Economics and Statistics 81 4 (1999) 681-693
17. Sillamaa M.A., and Veall M.R. The effect of marginal tax rates on taxable income: a panel study of the 1988 tax flattening in Canada. Journal of Public Economics 80 (2001) 341-356
18. Contoyannis P., Hurley J., Grootendorst P., Jeon S.H., and Tamblyn R. Estimating the price elasticity of expenditure for prescription drugs in the presence of non-linear price schedules: an illustration from Quebec, Canada. Health Economics 14 (2005) 909-923
19. Lacaille D., Anis A.H., Guh D., and Esdaile J. Gaps in care for rheumatoid arthritis: a population study. Arthritis and Rheumatism 53 2 (2005) 241-248
20. Silman A., and Hochberg M.C. Rheumatoid arthritis. In: Silman A., and Hochberg M.C. (Eds). Epidemiology of the rheumatic diseases (1993), Oxford Press, Oxford 7-68
21. Harris B.L., Stergachis A., and Ried L.D. The effect of drug co-payments on utilization and cost of pharmaceuticals in a health maintenance organization. Medical Care 28 10 (1990) 907-917
22. Smith D. The effect of co-payments and generic substitution on the use and costs of prescription drugs. Inquiry 30 (1993) 189-198
23. O'Brien B. The effect of patient charges on the utilization of prescription medicines. Journal of Health Economics 8 1 (1989) 109-132
24. Hughes D., and McGuire A. Patient charges and the utilization of NHS prescription medicines. Health Economics 4 3 (1995) 213-220
25. Landsman P.B., Yu W., Liu X., Teutsch S.M., and Berger M.L. Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilization. American Journal of Managed Care 11 (2005) 621-628
26. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis and Rheumatism 46 (2002) 328-346
27. Coulson N.E., Terza J.V., Neslusan C.A., et al. Estimating the moral-hazard effect of supplemental medical insurance in the demand for prescription drugs by the elderly. American Economic Review 58 2 (1995) 122-126
28. Foreman RJ, Stratmann T. How sensitive are seniors to the price of prescription drugs? Working paper. George Mason University; 2003.